A participant of a breakthrough drug trial in treating Covid-19 has stated he wouldn’t be right here right now if he had not been concerned.
John Hanna, from Inverclyde, was so in poor health with the virus in 2020, he was positioned in a medically induced coma.
His spouse enrolled him within the Restoration trial for dexmethasone, which is now estimated to have saved a million lives around the globe – together with 22,000 within the UK.
He stated: “My spouse enrolled me within the Restoration trial as a final ray of hope for therapy.
“That call modified every thing. With out the docs and analysis groups working across the clock to seek out out which remedies labored, and which didn’t, I wouldn’t be right here right now.”
On June 16 2020, researchers discovered dexamethasone decreased deaths by as much as one third in what was a breakthrough for the examine which was introduced on the primary day of the nationwide UK lockdown on March 23, 2020.
It was primarily funded by UK Analysis and Innovation (UKRI), and the Nationwide Institute for Well being and Care Analysis (NIHR) with a joint funding of £2.1 million, after a name for analysis proposals in early February 2020.
After two weeks, 1,000 contributors had joined the trial and 5 weeks later, 10,000 folks had joined.
The examine additionally discovered that antimalarial drug hydroxychloroquine had no medical profit and lopinavir-ritonavir was not efficient in decreasing deaths.
Prof Patrick Chinnery, medical director at UKRI’s Medical Analysis Council stated: “Many affected person lives have been saved through the use of dexamethasone in sufferers with extreme Covid-19.
“Two years on, we mirror on the unbelievable efforts from all these concerned within the trials which helped us deal with the pandemic.”